These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 15585408
1. Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease. Dong Z, Wolfer DP, Lipp HP, Büeler H. Mol Ther; 2005 Jan; 11(1):80-8. PubMed ID: 15585408 [Abstract] [Full Text] [Related]
3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L, Garris BL, Garris DR, Lau YS. Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572 [Abstract] [Full Text] [Related]
7. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease. Corona JC, Gimenez-Cassina A, Lim F, Díaz-Nido J. J Neurosci Res; 2010 Jul 19; 88(9):1943-50. PubMed ID: 20143419 [Abstract] [Full Text] [Related]
9. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway. Teng X, Sakai T, Liu L, Sakai R, Kaji R, Fukui K. J Neurochem; 2006 May 19; 97(4):1126-35. PubMed ID: 16686692 [Abstract] [Full Text] [Related]
12. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E. Exp Neurol; 2004 Apr 19; 186(2):158-72. PubMed ID: 15026254 [Abstract] [Full Text] [Related]
13. Neuroprotection in Parkinson models varies with toxin administration protocol. Anderson DW, Bradbury KA, Schneider JS. Eur J Neurosci; 2006 Dec 19; 24(11):3174-82. PubMed ID: 17156378 [Abstract] [Full Text] [Related]
14. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats. Rojo AI, Cavada C, de Sagarra MR, Cuadrado A. Exp Neurol; 2007 Nov 19; 208(1):120-6. PubMed ID: 17880941 [Abstract] [Full Text] [Related]
15. Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice. Liang Y, Li S, Zou Q, Su B. Neurosci Lett; 2006 Jun 12; 400(3):213-7. PubMed ID: 16540245 [Abstract] [Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model. Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y. Eur J Neurosci; 2009 Mar 12; 29(5):891-900. PubMed ID: 19245369 [Abstract] [Full Text] [Related]
17. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Holmer HK, Keyghobadi M, Moore C, Menashe RA, Meshul CK. Synapse; 2005 Aug 12; 57(2):100-12. PubMed ID: 15906381 [Abstract] [Full Text] [Related]
18. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ. Exp Neurol; 2002 May 12; 175(1):35-48. PubMed ID: 12009758 [Abstract] [Full Text] [Related]
20. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice. Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M. Neurosci Lett; 2006 Jun 19; 401(1-2):183-7. PubMed ID: 16581184 [Abstract] [Full Text] [Related] Page: [Next] [New Search]